FDA ap­proves first two in­ter­change­able biosim­i­lars to Re­gen­eron's block­buster Eylea

Eylea will even­tu­al­ly have com­pe­ti­tion in the US, as the FDA ap­proved two in­ter­change­able biosim­i­lars.

Mon­day’s ap­provals for Bio­con Bi­o­log­ics’ Yesafili and Sam­sung Bioepis and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER